Ipca Laboratories gains 3% on USFDA classification
The VAI classification, considered the second best, comes afterpharma company's Piparia facility in Silvassa had undergone US FDA inspection in April.
Source: moneycontrol.com
Stay updated with breaking news from Ipca Laboratories. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The VAI classification, considered the second best, comes afterpharma company's Piparia facility in Silvassa had undergone US FDA inspection in April.
The Nifty Pharma index closed 0.58 per cent down at 15193.15.
Motilal Oswal recommended Neutral rating on Ipca Laboratories with a target price of Rs 840 in its research report dated August 12, 2023.
The Nifty Pharma index closed 0.13 per cent down at 15282.5.
Leading Atenolol Market player include Research Report by Research Nester are Abbott Laboratories, F. Hoffmann-La Roche AG, Danaher Corporation, Bio-Rad...